AR054208A1 - Derivados de oxopiperidina, su preparacion, una composicion farmaceutica y compuestos intermediarios - Google Patents
Derivados de oxopiperidina, su preparacion, una composicion farmaceutica y compuestos intermediariosInfo
- Publication number
- AR054208A1 AR054208A1 AR20050103084A ARP050103084A AR054208A1 AR 054208 A1 AR054208 A1 AR 054208A1 AR 20050103084 A AR20050103084 A AR 20050103084A AR P050103084 A ARP050103084 A AR P050103084A AR 054208 A1 AR054208 A1 AR 054208A1
- Authority
- AR
- Argentina
- Prior art keywords
- cycloalkyl
- heterocycloalkyl
- heteroaryl
- aryl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente se refiere a derivados de oxopiperidina de formula general (1), a un procedimiento para su preparacion, a medicamentos y composiciones farmacéuticas en base a ellos y a compuestos intermediarios de síntesis. Estos compuestos son de aplicacion en el tratamiento y prevencion de la obesidad, diabetes y disfunciones sexuales y el tratamiento de enfermedades cardiovasculares. Reivindicacion 1: Compuesto que responde a la formula (1): en la cual: n es igual a 1; Ra, Ra', Rb y Rb' son idénticos o diferentes entre sí, y representan un átomo de hidrogeno o un grupo alquilo o cicloalquilo, Rb y Rb' pueden formar juntos, con los átomos de carbono del ciclo al que están unidos, un puente carbonado que comprende de 4 a 5 eslabones; R1 representa un grupo alquilo o cicloalquilo; R2 representa un grupo heteroarilo; R3 representa 1 a 3 grupos, idénticos o diferentes entre sí, situados en posiciones cualesquiera del nucleo al cual están unidos, y elegidos, entre los átomos de halogeno y los grupos alquilos, cicloalquilos, -OR, -NRR', -CO-NRR', -NR-CO-R', -NR-CONRR', -NR-COOR', -NO2, -CN y -COOR; R5 representa un átomo de hidrogeno, un grupo alquilo, o cicloalquilo; R4 se elige entre los grupos de formulas (a), (b) y (c) que se presentan más adelante, eventualmente, substituidos por un grupo oxo, o mono- o polisubstituido por un grupo arilo o heteroarilo; en las cuales p = 0, 1, 2 o 3, m = 0, 1 o 2, y, o bien a) X representa un eslabon -N(R10) -, donde R10, se elige entre: ò un grupo (CH2)x-OR8, (CH2)x-COOR8, -(CH2)x-NR8R9, (CH2)x-CO-NR8R9 o -(CH2)x-NR8-COR9, -(CH2)x-COR8 en los cuales x = 1, 2, 3 o 4; ò un grupo cicloalquilo o heterocicloalquilo fusionado con un grupo arilo o heteroarilo; ò un grupo cicloalquilo, heterocicloalquilo, arilo, heteroarilo, alquilarilo, alquilheteroarilo, -CO-alquilo, -CO-cicloalquilo, -CO-heterocicloalquilo, -CO-arilo, -CO-heteroarilo, -CO-alquilarilo, -CO-alquilheteroarilo, -CS-alquilo, -CS-cicloalquilo, -CS- heterocicloalquilo, -CS-arilo, -CS-heteroarilo, -CS-alquilarilo, -CS-alquilheteroarilo, -CS-NR8R9, C(=NH)-NR8R9, -SO2-alquilo-, -SO2-cicloalquilo, -SO2-heterocicloalquilo, -SO2-arilo, -SO2-heteroarilo, -SO2-alquilarilo, -SO2-alquilheteroarilo o -SO2- NR8R9, los grupos alquilos, cicloalquilos, heterocicloalquilos, arilos, heteroarilos están eventualmente substituidos por 1 o varios grupos elegidos entre los átomos de halogeno y los grupos R, R', OR, NRR', -CO-NRR', -NRCOR', NRCONRR', -NO2, CN, - COOR, OCOR, COR,, OCONRR', NRCOOR'; los grupos cicloalquilos, heterocicloalquilos, están eventualmente fusionados con un grupo arilo o heteroarilo; o bien R10 forma con el átomo de nitrogeno al cual está unido y un átomo de carbono situado en una posicion cualquiera de la estructura cíclica de la formula (a), pero no adyacente a dicho átomo de nitrogeno, un puente que comprende de 3 a 5 eslabones, R8 y R9 se eligen, independientemente entre si, entre un átomo de hidrogeno y los grupos alquilos, cicloalquilos, heterocicloalquilos, arilos, heteroarilos, alquilarilos, alquilheteroarilos, -CO-alquilos, -CO-cicloalquilos, -CO-heterocicloalquilos, -CO-arilos, -CO-heteroarilos, -CO-alquilarilos, -CO-alquilheteroarilos, -SO2-alquilos, - SO2-cicloalquilos, -SO2-heterocicloalquilos, -SO2-arilos, -SO2-heteroarilos, -SO2-alquilarilos, -SO2-alquilheteroarilos, -C(=NH)-NRR', -COOR, -CO-NRR', -CS-NRR' y -(CH2)x-OR, donde x = 0, 1, 2, 3 o 4, los grupos alquilos, cicloalquilos, heterocicloalquilos, arilos y heteroarilos están substituidos, eventualmente, por uno o varios grupos elegidos entre los átomos de halogeno y los grupos R, R', OR, NRR', -CO-NRR', -NRCOR', NRCONRR', -NO2, CN, -COOR, OCOR, COR, OCONRR', NRCOOR'; o bien R8 y R9 forman juntos un cicloalquilo o un heterocicloalquilo; R y R' representan, independientemente entre si, un átomo de hidrogeno o un grupo alquilo, cicloalquilo, heterocicloalquilo, arilo, heteroarilo, alquilarilo o alquilheteroarilo, o pueden formar juntos un cicloalquilo o un heterocicloalquilo; o bien, b) X representa un eslabon -C(R6)(R7)-, donde R6 se elige entre: ò un átomo de hidrogeno, un átomo de halogeno; ò un grupo (CH2)x-OR8, (CH2)x-COOR8, -(CH2)x-NR8R9, (CH2)x-CO-NR8R9 o -(CH2)x-NR8-COR9, -(CH2)x-COR8 en los cuales x = 1, 2, 3 o 4; ò un grupo alquilo, cicloalquilo, heterocicloalquilo, arilo, heteroarilo, alquilarilo, alquilheteroarilo, -CO-alquilo, -CO-cicloalquilo, -CO-heterocicloalquilo, -CO-arilo, -CO- heteroarilo, -CO-alquilarilo, -CO-alquilheteroarilo, -CS-alquilo, -CS-cicloalquilo, -CS-heterocicloalquilo, -CS-arilo, -CS-heteroarilo, -CS-alquilarilo, -CS-alquilheteroarilo, -CS-NR8R9, C(=NH)-NR8R9; ò un grupo cicloalquilo o heterocicloalquilo, fusionado o no, situado en posicion espiro sobre el ciclo de formula (a) al cual está unido; un grupo cicloalquilo o heterocicloalquilo fusionado con un grupo arilo o heteroarilo; los grupos alquilos, cicloalquilos, heterocicloalquilos, arilos o heteroarilos están substituidos, eventualmente, por uno o varios grupos elegidos entre los átomos de halogeno y los grupos R, R', OR, NRR', -CO-NRR', -NRCOR', NRCONRR', -NO2, CN, -COOR, OCOR, COR, OCONRR', NRCOOR'; los grupos cicloalquilos o heterocicloalquilos están eventualmente fusionados con un grupo arilo o heteroarilo; R7 se elige entre los átomos de halogeno y los grupos alquilos, cicloalquilos, arilos, heteroarilos, alquilarilos, alquilheteroarilos, -OR, -O-arilos, -O- heteroarilos, -O-alquilarilos, -O-alquilheteroarilos, -NRR', -CO-NRR', -NR-CO-R', -NR-CO-NRR', -NR-COOR', -NO2, -CN y -COOR; R8 y R9, se eligen, independientemente entre si, entre un átomo de hidrogeno y los grupos alquilos, cicloalquilos, heterocicloalquilos, arilos, heteroarilos, alquilarilos, alquilheteroarilos, -CO-alquilos, -CO-cicloalquilos, -CO-heterocicloalquilos, -CO-arilos, -CO-heteroarilos, -CO-alquilarilos, -CO-alquilheteroarilos, -SO2-alquilos, -SO2-cicloalquilos, -SO2- heterocicloalquilos, -SO2-arilos, -SO2-heteroarilos, -SO2-alquilarilos, -SO2-alquilheteroarilos, -C(=NH)-NRR', -COOR, -CO-NRR', -CS NRR' y -(CH2)x-OR, donde x = 0, 1, 2, 3 o 4, los grupos alquilos, cicloalquilos, heterocicloalquilos, arilos y heteroarilos están substituidos, eventualmente, por uno o varios grupos elegidos entre los átomos de halogeno y los grupos R, R', OR, NRR', -CO-NRR', -NRCOR', NRCONRR', -NO2, CN, -COOR, OCOR, COR, OCONRR', NRCOOR'; o bien R8 y R9 forman juntos un cicloalquilo o un heterocicloalquilo; R y R' representan, independientemente entre si, un átomo de hidrogeno o un grupo alquilo, cicloalquilo, heterocicloalquilo, arilo, heteroarilo, alquilarilo o alquilheteroarilo, o pueden formar juntos un cicloalquilo o un heterocicloalquilo, en estado de base o de sal de adicion con un ácido, así como en estado de hidrato o de solvato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408369A FR2873690B1 (fr) | 2004-07-29 | 2004-07-29 | Derives d'oxopiperidine, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054208A1 true AR054208A1 (es) | 2007-06-13 |
Family
ID=34947722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR20050103084A AR054208A1 (es) | 2004-07-29 | 2005-07-26 | Derivados de oxopiperidina, su preparacion, una composicion farmaceutica y compuestos intermediarios |
Country Status (25)
Country | Link |
---|---|
US (1) | US20070149562A1 (es) |
EP (1) | EP1773796B1 (es) |
JP (1) | JP4871866B2 (es) |
KR (1) | KR20070047802A (es) |
CN (1) | CN101010309A (es) |
AR (1) | AR054208A1 (es) |
AT (1) | ATE459608T1 (es) |
AU (1) | AU2005276353C1 (es) |
BR (1) | BRPI0512680A (es) |
CA (1) | CA2577177A1 (es) |
CY (1) | CY1110124T1 (es) |
DE (1) | DE602005019743D1 (es) |
DK (1) | DK1773796T3 (es) |
ES (1) | ES2341722T3 (es) |
FR (1) | FR2873690B1 (es) |
IL (1) | IL180770A (es) |
MX (1) | MX2007001139A (es) |
PE (1) | PE20060563A1 (es) |
PL (1) | PL1773796T3 (es) |
PT (1) | PT1773796E (es) |
RU (1) | RU2376298C2 (es) |
SI (1) | SI1773796T1 (es) |
TW (1) | TW200609217A (es) |
UY (1) | UY29036A1 (es) |
WO (1) | WO2006021655A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873691B1 (fr) * | 2004-07-29 | 2006-10-06 | Sanofi Synthelabo | Derives d'amino-piperidine, leur preparation et leur application en therapeutique |
RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
EP2020405A1 (en) * | 2007-07-30 | 2009-02-04 | Santhera Pharmaceuticals (Schweiz) AG | Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013134376A1 (en) * | 2012-03-06 | 2013-09-12 | Vanderbilt University | Positive allosteric modulators for melanocortin receptors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968929A (en) * | 1996-10-30 | 1999-10-19 | Schering Corporation | Piperazino derivatives as neurokinin antagonists |
AU766191B2 (en) * | 1999-06-04 | 2003-10-09 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
JP2003528088A (ja) * | 2000-03-23 | 2003-09-24 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体作働薬としての置換ピペリジン類 |
CA2419310A1 (en) * | 2000-08-23 | 2002-02-28 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
EP1363631A4 (en) * | 2001-03-02 | 2005-11-16 | Bristol Myers Squibb Co | "COMPOUNDS SUITED AS MODULATORS OF MELANOCORTIN RECEPTORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF" |
CA2453609C (en) * | 2001-07-18 | 2010-05-04 | Merck & Co., Inc. | Bridged piperidine derivatives as melanocortin receptor agonists |
US6977264B2 (en) * | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
US20040010010A1 (en) * | 2002-04-30 | 2004-01-15 | Ebetino Frank Hallock | Melanocortin receptor ligands |
US7049323B2 (en) * | 2003-04-25 | 2006-05-23 | Bristol-Myers Squibb Company | Amidoheterocycles as modulators of the melanocortin-4 receptor |
KR20050045927A (ko) * | 2003-11-12 | 2005-05-17 | 주식회사 엘지생명과학 | 멜라노코틴 수용체의 항진제 |
FR2873691B1 (fr) * | 2004-07-29 | 2006-10-06 | Sanofi Synthelabo | Derives d'amino-piperidine, leur preparation et leur application en therapeutique |
FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
-
2004
- 2004-07-29 FR FR0408369A patent/FR2873690B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-20 BR BRPI0512680-0A patent/BRPI0512680A/pt not_active IP Right Cessation
- 2005-07-20 JP JP2007523108A patent/JP4871866B2/ja not_active Expired - Fee Related
- 2005-07-20 DK DK05790990.5T patent/DK1773796T3/da active
- 2005-07-20 SI SI200531010T patent/SI1773796T1/sl unknown
- 2005-07-20 EP EP05790990A patent/EP1773796B1/fr active Active
- 2005-07-20 ES ES05790990T patent/ES2341722T3/es active Active
- 2005-07-20 CA CA002577177A patent/CA2577177A1/fr not_active Abandoned
- 2005-07-20 AT AT05790990T patent/ATE459608T1/de active
- 2005-07-20 PL PL05790990T patent/PL1773796T3/pl unknown
- 2005-07-20 RU RU2007107374/04A patent/RU2376298C2/ru not_active IP Right Cessation
- 2005-07-20 AU AU2005276353A patent/AU2005276353C1/en not_active Ceased
- 2005-07-20 MX MX2007001139A patent/MX2007001139A/es active IP Right Grant
- 2005-07-20 PT PT05790990T patent/PT1773796E/pt unknown
- 2005-07-20 DE DE602005019743T patent/DE602005019743D1/de active Active
- 2005-07-20 KR KR1020077004655A patent/KR20070047802A/ko not_active Application Discontinuation
- 2005-07-20 WO PCT/FR2005/001854 patent/WO2006021655A2/fr active Application Filing
- 2005-07-20 CN CNA2005800292206A patent/CN101010309A/zh active Pending
- 2005-07-26 AR AR20050103084A patent/AR054208A1/es not_active Application Discontinuation
- 2005-07-27 UY UY29036A patent/UY29036A1/es not_active Application Discontinuation
- 2005-07-27 PE PE2005000879A patent/PE20060563A1/es not_active Application Discontinuation
- 2005-07-28 TW TW094125682A patent/TW200609217A/zh unknown
-
2007
- 2007-01-17 IL IL180770A patent/IL180770A/en not_active IP Right Cessation
- 2007-01-25 US US11/626,970 patent/US20070149562A1/en not_active Abandoned
-
2010
- 2010-06-01 CY CY20101100481T patent/CY1110124T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006021655A8 (fr) | 2007-05-24 |
EP1773796A2 (fr) | 2007-04-18 |
PE20060563A1 (es) | 2006-07-12 |
SI1773796T1 (sl) | 2010-07-30 |
ES2341722T3 (es) | 2010-06-25 |
UY29036A1 (es) | 2006-02-24 |
PL1773796T3 (pl) | 2010-08-31 |
AU2005276353B2 (en) | 2011-12-01 |
TW200609217A (en) | 2006-03-16 |
IL180770A0 (en) | 2007-06-03 |
FR2873690B1 (fr) | 2006-10-13 |
ATE459608T1 (de) | 2010-03-15 |
DE602005019743D1 (de) | 2010-04-15 |
DK1773796T3 (da) | 2010-06-21 |
JP2008508240A (ja) | 2008-03-21 |
JP4871866B2 (ja) | 2012-02-08 |
AU2005276353A1 (en) | 2006-03-02 |
AU2005276353C1 (en) | 2012-03-29 |
IL180770A (en) | 2011-10-31 |
MX2007001139A (es) | 2007-04-19 |
RU2376298C2 (ru) | 2009-12-20 |
PT1773796E (pt) | 2010-06-01 |
BRPI0512680A (pt) | 2008-04-01 |
WO2006021655A2 (fr) | 2006-03-02 |
FR2873690A1 (fr) | 2006-02-03 |
EP1773796B1 (fr) | 2010-03-03 |
CY1110124T1 (el) | 2015-01-14 |
KR20070047802A (ko) | 2007-05-07 |
RU2007107374A (ru) | 2008-09-10 |
US20070149562A1 (en) | 2007-06-28 |
CN101010309A (zh) | 2007-08-01 |
WO2006021655A3 (fr) | 2006-04-20 |
CA2577177A1 (fr) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054208A1 (es) | Derivados de oxopiperidina, su preparacion, una composicion farmaceutica y compuestos intermediarios | |
AR050186A1 (es) | Derivados de amino-piperidina, su preparacion y su aplicacion en terapeutica. | |
AR056195A1 (es) | Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos | |
AR104417A2 (es) | Compuestos de tiadiazolidina, procedimiento para su preparación, composición farmacéutica que lo compone y usos de dichos compuestos | |
AR084720A1 (es) | Inhibidores de anillos fusionados triciclicos de hepatitis c | |
AR057959A1 (es) | 5-pirazolpiperidinas-(sustituidas) | |
AR050019A1 (es) | Derivados de amino-tropano con actividad agonista de los receptores de melanocortinas, su preparacion, composiciones farmaceuticas que los contienen y su empleo en medicamentos para el tratamiento de enfermedades en las cuales estan implicados los receptores mc3 y/o mc4 | |
CO6251201A2 (es) | Composiciones y metodos para el tratamiento de3 enfermedades y desordenes oftalmicos | |
AR081848A1 (es) | Inhibidores de la proteina ns5a del vhc | |
AR044874A1 (es) | Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica | |
AR037489A1 (es) | Quinolinas sustituidas y proceso para su preparacion | |
AR043700A1 (es) | Derivados de 3-substituida-4-pirimidona | |
AR070437A1 (es) | Moduladores de beta - amiloide | |
AR038843A1 (es) | Derivados de fenetanolamina para el tratamiento de enfermedades respiratorias | |
AR054186A1 (es) | Derivados de tetrahidroindazolona y tetrahidroindolona | |
AR045010A1 (es) | Pirimidinas utiles como moduladores de canales ionicos cuya activacion es controlada por tension | |
AR058728A1 (es) | Derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina, metodo de preparacion,medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos. | |
AR067027A1 (es) | Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a. | |
ES2603931T3 (es) | Compuestos de triazolo | |
AR084430A1 (es) | Di/tri-aza-espiro-alcanos c | |
ECSP088105A (es) | Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparación y su aplicación en terapéutica | |
AR070655A1 (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas | |
AR064136A1 (es) | Derivados de espiro-piperidina, metodos para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades relacionadas con la accion antagonista del receptor v1a. | |
AR069813A1 (es) | Derivados de 2- amino-pirimidina, una composicion farmaceutica, un metodo de preparacion del compuesto y uso del mismo para preparar un medicamento | |
CO2020001326A2 (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |